TABLE 3.

Baseline predictors of ACM from the Cox Proportional Hazards Model in the atorvastatin 10 mg group

Baseline factors	H (P value)	95% Confidence interval
Treatment group (T/A versus A)	2.67 (<0.001)	(1.57, 4.54)
Age >70 yearsa	3.51 (<0.001)	(1.76, 6.98)
Age 61–70a	2.20 (0.014)	(1.17, 4.12)
History of CHF	3.20 (< 0.001)	(1.80, 5.69)
History of stroke	2.76 (0.002)	(1.46, 5.20)
CRP > 7.5 mg/lb	2.67 (0.004)	(1.36, 5.23)
CRP >3–7.5 mg/lb	1.81 (0.038)	(1.03, 3.17)

T/A, torcetrapib plus atorvastatin; A, atorvastatin alone; CHF, congestive heart failure; CRP, C reactive protein. A treatment hazard ratio >1 indicates increased risk in the T/A treatment group compared with the A treatment group.

^aRelative to age ≤ 60.

^bRelative to CRP ≤ 3 mg/l.